SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo
📖

Tissue Engineered Nigrostriatal Pathway for Parkinson's Disease

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-therapeutics-tissue-engineered-nigr
Related Entities
therapeutics-tissue-engineered-nigrostriatal-pathway
Metadata
slugtherapeutics-tissue-engineered-nigrostriatal-pathway
entity_typetreatment
kg_node_idNone
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (491)
mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%
related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%
mentions🧪Noradrenergic-Tau Propagation Blockade70%
mentions🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors70%
mentions🧪Transcriptional Autophagy-Lysosome Coupling70%
mentions🧪HSP90-Tau Disaggregation Complex Enhancement70%
mentions🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati70%
mentions🧪Synaptic Vesicle Tau Capture Inhibition70%
mentions🧪Autophagosome Maturation Checkpoint Control70%
mentions🧪VCP-Mediated Autophagy Enhancement70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧪HSP90-Tau Disaggregation Complex Enhancement70%
related🧪VCP-Mediated Autophagy Enhancement70%
related🧪Noradrenergic-Tau Propagation Blockade70%
related🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors70%
related🧪Autophagosome Maturation Checkpoint Control70%
related🧪Synaptic Vesicle Tau Capture Inhibition70%
related🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati70%
related🧪Transcriptional Autophagy-Lysosome Coupling70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
see_also📖Cell-Free DNA Biomarkers in Neurodegeneration60%
see_also📖Exosomal Biomarkers in Neurodegeneration60%
see_also📖Exosomal miR-155 in Neurodegeneration60%
see_also📖IL-6 (Interleukin-6) in Neurodegeneration60%
see_also📖Liquid Biopsy in Neurodegeneration60%
see_also📖Metabolomic Biomarkers in Neurodegeneration60%
see_also📖Neuroimaging Biomarkers for Neurodegeneration60%
see_also📖Synaptic Biomarkers in Neurodegeneration60%
see_also📖BEACoN Study - Biomarker Exploration in Aging, Cognition and60%
see_also📖Olfactory Mucosa, Blood and Urine for Identification of Earl60%
see_also📖Swedish BioFINDER 2 Study: Biomarkers and Neurodegeneration 60%
see_also📖Beta-Propeller Protein-Associated Neurodegeneration (BPAN)60%
see_also📖China Neurodegeneration Epidemiology60%
see_also📖DALY Methodology — Neurodegeneration60%
see_also📖Disease Progression & Staging in Neurodegeneration60%
see_also📖Economic Burden — Neurodegeneration60%
see_also📖European Neurodegeneration Epidemiology60%
see_also📖Familial vs Sporadic Neurodegeneration Comparison60%
see_also📖Global Neurodegeneration Epidemiology60%
see_also📖India Neurodegeneration Epidemiology60%
see_also📖Japan Neurodegeneration Epidemiology60%
see_also📖Manganese-Related Neurodegeneration (Manganism)60%
see_also📖mitochondrial-dysfunction-neurodegeneration-comparison60%
see_also📖Mitochondrial Diseases and Neurodegeneration Comparison Matr60%
see_also📖Mitochondrial Membrane Protein-Associated Neurodegeneration 60%
see_also📖Neurodegeneration with Brain Iron Accumulation (NBIA)60%
see_also📖Potential Impact Measures — Neurodegeneration60%
see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)60%
see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)60%
see_also📖PLA2G6-Associated Neurodegeneration (PLAN)60%
see_also📖Sleep Disorders in Neurodegeneration60%
see_also📖US Neurodegeneration Epidemiology60%
see_also📖Extracellular Vesicle and Tunneling Nanotube-Mediated Spread60%
see_also📖acetylcholine-signaling-neurodegeneration60%
see_also📖Advanced Glycation End Products in Neurodegeneration60%
see_also📖Advanced In Vitro Models for Neurodegeneration — Organoids, 60%
see_also📖Amylin Signaling in Neurodegeneration60%
see_also📖Antibody Therapy in Neurodegeneration60%
see_also📖Antisense Oligonucleotide (ASO) Therapy in Neurodegeneration60%
see_also📖Autosis Pathway in Neurodegeneration60%
see_also📖Axon Guidance Pathways in Neurodegeneration60%
see_also📖Basal Ganglia Circuit Dysfunction in Neurodegeneration60%
see_also📖becn1-autophagy-initiation-neurodegeneration-causal-chain60%
see_also📖CaMKII Signaling Pathway in Neurodegeneration60%
see_also📖Carbonic Anhydrase Modulator Therapy in Neurodegeneration60%
see_also📖Cerebral Amyloid Angiopathy in Neurodegeneration60%
see_also📖Cerebral Amyloid Angiopathy Pathway in Neurodegeneration60%
see_also📖Cholinergic System Dysfunction in Neurodegeneration60%
see_also📖Chrononutrition and Time-Restricted Eating in Neurodegenerat60%
see_also📖Neural Circuits in Neurodegeneration60%
see_also📖Cognitive Reserve and Resilience in Neurodegeneration60%
see_also📖Computational Disease Models for Neurodegeneration60%
see_also📖Convergent Pathways in Neurodegeneration60%
see_also📖Copper Homeostasis in Neurodegeneration60%
see_also📖COVID-19 Neurodegeneration Mechanism60%
see_also📖Diffusion MRI (DTI) in Neurodegeneration60%
see_also📖Digital Phenotyping in Neurodegeneration60%
see_also📖Down Syndrome Neurodegeneration Pathway60%
see_also📖Dystrophic Neurites in Neurodegeneration60%
see_also📖Endocannabinoid System in Neurodegeneration60%
see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration60%
see_also📖Endosomal Sorting Defects in Neurodegeneration60%
see_also📖Endothelin Signaling Pathway in Neurodegeneration60%
see_also📖epigenetics-neurodegeneration60%
see_also📖ESCRT-III Inhibition by Alpha-Synuclein in Neurodegeneration60%
see_also📖FA2H-Associated Neurodegeneration Pathway60%
see_also📖Farnesoid X Receptor (FXR) Signaling in Neurodegeneration60%
see_also📖Galectin-3 Mechanism in Neurodegeneration60%
see_also📖Gangliosides in Neurodegeneration60%
see_also📖GDF15/GDF11 Signaling in Neurodegeneration60%
see_also📖GDNF Signaling Pathway in Neurodegeneration60%
see_also📖Ghrelin Signaling Pathway in Neurodegeneration60%
see_also📖Glucocorticoid Signaling Pathway in Neurodegeneration60%
see_also📖Glycosylation in Neurodegeneration60%
see_also📖gp130/IL-6 Family Cytokine Signaling in Neurodegeneration60%
see_also📖Hippocampal Neurogenesis in Neurodegeneration60%
see_also📖Histone Modification Pathways in Neurodegeneration60%
see_also📖HMGB1 Signaling in Neurodegeneration60%
see_also📖Homocysteine Neurotoxicity and Neurodegeneration60%
see_also📖IGF-1 Signaling Pathway in Neurodegeneration60%
see_also📖IL-1 Signaling Pathway in Neurodegeneration60%
see_also📖Integrated Stress Response in Neurodegeneration60%
see_also📖interleukin-6-signaling-neurodegeneration60%
see_also📖Intrinsic Apoptosis Pathway in Neurodegeneration60%
see_also📖Ion Channel Dysfunction in Neurodegeneration: Cross-Disease 60%
see_also📖Kidney-Brain Neurodegeneration Axis60%
see_also📖Lipid Dysregulation in Neurodegeneration60%
see_also📖Lipid Metabolism Dysregulation in Neurodegeneration60%
see_also📖Lysosomal Calcium Dysregulation in Neurodegeneration60%
see_also📖Magnetic Resonance Spectroscopy in Neurodegeneration60%
see_also📖Metal Homeostasis Dysregulation in Neurodegeneration60%
see_also📖Metal Homeostasis in Neurodegeneration60%
see_also📖Microglial Priming Pathway in Neurodegeneration60%
see_also📖MicroRNA Dysfunction in Neurodegeneration60%
see_also📖Mineralocorticoid Receptor Signaling in Neurodegeneration60%
see_also📖Mitochondrial Dynamics Pathway in Neurodegeneration60%
see_also📖Mitochondrial Fusion in Neurodegeneration60%
see_also📖Molecular Chaperones in Neurodegeneration60%
see_also📖mTOR Signaling in Neurodegeneration60%
see_also📖mTOR Signaling Pathway in Neurodegeneration60%
see_also📖Neural Circuit Disruption in Neurodegeneration60%
see_also📖Neurexin/Neuroligin Synaptic Adhesion Modulator Therapy in N60%
see_also📖Neurofilament Light Chain (NfL) Mechanism in Neurodegenerati60%
see_also📖Neuronal Hyperexcitability in Neurodegeneration60%
see_also📖Neuropil Threads in Neurodegeneration60%
see_also📖Neurotensin Signaling in Neurodegeneration60%
see_also📖Neurovascular Unit Dysfunction in Neurodegeneration60%
see_also📖NF-kB Signaling Pathway in Neurodegeneration60%
see_also📖Nitric Oxide Signaling in Neurodegeneration60%
see_also📖Noradrenergic Signaling Pathway in Neurodegeneration60%
see_also📖Neuropeptide Y Signaling in Neurodegeneration60%
see_also📖NRF2 Signaling Pathway in Neurodegeneration60%
see_also📖Nuclear Pore Complex Dysfunction in Neurodegeneration60%
see_also📖Orexin Signaling in Neurodegeneration60%
see_also📖OSK Reprogramming and Yamanaka Factors in Neurodegeneration60%
see_also📖P-Body (Processing Body) Pathway in Neurodegeneration60%
see_also📖Paranodal Dysfunction in Neurodegeneration60%
see_also📖Paraptosis in Neurodegeneration60%
see_also📖Parthanatos in Neurodegeneration60%
see_also📖Pericyte Loss in Neurodegeneration60%
see_also📖Peripheral Immune-Brain Crosstalk in Neurodegeneration60%
see_also📖PKR Pathway in Neurodegeneration60%
see_also📖PPAR Signaling Pathway in Neurodegeneration60%
see_also📖Prion Diseases in Neurodegeneration60%
see_also📖Prion-Like Spread in Neurodegeneration60%
see_also📖Prion Protein Metabolism in Neurodegeneration60%
see_also📖Progesterone Signaling Pathway in Neurodegeneration60%
see_also📖Prognostic Biomarkers in Neurodegeneration60%
see_also📖Protein Aggregation Comparison in Neurodegeneration60%
see_also📖Protein Aggregation Seeds in Neurodegeneration60%
see_also📖Protein O-GlcNAcylation Pathway in Neurodegeneration60%
see_also📖Cortical Involvement and Neurodegeneration in Progressive Su60%
see_also📖Purinergic Signaling in Neurodegeneration60%
see_also📖Quantum Biology and Coherent Energy Transfer in Neurodegener60%
see_also📖R-Loop Stress in Neurodegeneration60%
see_also📖RAN Translation in Neurodegeneration60%
see_also📖Retinal Degeneration Pathway in Neurodegeneration60%
see_also📖Ribosome Dysfunction in Neurodegeneration60%
see_also📖RNA Splicing in Neurodegeneration60%
see_also📖RNA-Targeted Therapies in Neurodegeneration60%
see_also📖Ribonuclease κ and Circular RNAs: A New Mechanism of Aging a60%
see_also📖S100 Protein Signaling Pathway in Neurodegeneration60%
see_also📖Senescent Cell Clearance in Neurodegeneration60%
see_also📖Serotonergic Dysfunction in Neurodegeneration60%
see_also📖Sex Differences in Neurodegeneration60%
see_also📖Short Chain Fatty Acids in Neurodegeneration60%
see_also📖Sigma-1 Receptor Signaling in Neurodegeneration60%
see_also📖Sirtuin-Mitochondrial Biogenesis Axis in Neurodegeneration60%
see_also📖Sleep Dysfunction in Neurodegeneration60%
see_also📖SUMOylation in Neurodegeneration60%
see_also📖synaptic-vesicle-cycling-neurodegeneration60%
see_also📖Synthetic Lethality and PARP Inhibition in Neurodegeneration60%
see_also📖T-Cell Dysfunction in Neurodegeneration60%
see_also📖Tertiary Lymphoid Organs in Neurodegeneration60%
see_also📖Therapeutic Targets in Neurodegeneration60%
see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration60%
see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration60%
see_also📖ubiquitin-proteasome-dysfunction-neurodegeneration60%
see_also📖Ubiquitin-Proteasome System Dysfunction in Neurodegeneration60%
see_also📖Vagus Nerve Pathway in Neurodegeneration60%
see_also📖VEGF Signaling and Cerebral Angiogenesis in Neurodegeneratio60%
see_also📖vip-vasoactive-intestinal-peptide-signaling-neurodegeneratio60%
see_also📖WNK1-Bilirubin Signaling in Neuroinflammation and Neurodegen60%
see_also📖Wnt/β-Catenin Signaling Pathway in Neurodegeneration60%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa60%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera60%
related🧫AAV-LRRK2 IND-Enabling Study Design60%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD60%
related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back60%
related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio60%
related🧫Computational Modeling of Alpha-Synuclein Propagation in PD60%
related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation60%
related🧫Alpha-Synuclein Seed Amplification Assay Validation60%
related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation60%
related🧫Antiviral Therapy Trial for Parkinson's Disease60%
related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&60%
related🧫Axonal Transport Dysfunction Validation in Parkinson's 60%
related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise60%
related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 60%
related🧫Combination Therapy Sequencing in Parkinson's Disease60%
related🧫CRISPR Gene Correction Approaches for CBS/PSP60%
related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa60%
related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#60%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i60%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#60%
related🧫Epigenetic Dysregulation Validation in Parkinson's Dise60%
related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD60%
related🧫Ferroptosis Validation in Parkinson's Disease60%
related🧫GLP-1 Agonist Neuroprotection Mechanism in PD60%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&60%
related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me60%
related🧫Cytochrome Therapeutics60%
related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson60%
related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown60%
related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design60%
related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne60%
related🧫Macroautophagy Dysfunction in PD - Experiment Design60%
related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P60%
related🧫Validation: Membrane-Nucleation in iPSC Neurons60%
related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr60%
related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 60%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag60%
related🧫MLCS Quantification in Parkinson's Disease60%
related🧫Experiment: Multi-Ethnic PD GWAS60%
related🧫Multiscale Computational Modeling of Protein Aggregation Kin60%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'60%
related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise60%
related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper60%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 60%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#60%
related🧫Parkinson's Disease Subtype Classification — Precision 60%
related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea60%
related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas60%
related🧫Prodromal Parkinson's Disease Biomarker Development — E60%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin60%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson60%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise60%
related🧫Sirtuin Dysfunction Validation in Parkinson's Disease60%
related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D60%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di60%
related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&60%
related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki60%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim60%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera54%
related🧫AAV-LRRK2 IND-Enabling Study Design54%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD54%
related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back54%
related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio54%
related🧫Computational Modeling of Alpha-Synuclein Propagation in PD54%
related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation54%
related🧫Alpha-Synuclein Seed Amplification Assay Validation54%
related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation54%
related🧫Antiviral Therapy Trial for Parkinson's Disease54%
related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&54%
related🧫Axonal Transport Dysfunction Validation in Parkinson's 54%
related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise54%
related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 54%
related🧫Combination Therapy Sequencing in Parkinson's Disease54%
related🧫CRISPR Gene Correction Approaches for CBS/PSP54%
related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa54%
related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#54%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i54%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#54%
related🧫Epigenetic Dysregulation Validation in Parkinson's Dise54%
related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD54%
related🧫Ferroptosis Validation in Parkinson's Disease54%
related🧫GLP-1 Agonist Neuroprotection Mechanism in PD54%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&54%
related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me54%
related🧫Cytochrome Therapeutics54%
related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson54%
related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown54%
related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design54%
related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne54%
related🧫Macroautophagy Dysfunction in PD - Experiment Design54%
related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P54%
related🧫Validation: Membrane-Nucleation in iPSC Neurons54%
related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr54%
related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 54%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag54%
related🧫MLCS Quantification in Parkinson's Disease54%
related🧫Experiment: Multi-Ethnic PD GWAS54%
related🧫Multiscale Computational Modeling of Protein Aggregation Kin54%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'54%
related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise54%
related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper54%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 54%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#54%
related🧫Parkinson's Disease Subtype Classification — Precision 54%
related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea54%
related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas54%
related🧫Prodromal Parkinson's Disease Biomarker Development — E54%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin54%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson54%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise54%
related🧫Sirtuin Dysfunction Validation in Parkinson's Disease54%
related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D54%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di54%
related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&54%
related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki54%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim54%
mentions🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio50%
mentions🧫tACS Connectivity Trial in Early Alzheimer's50%
mentions🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design50%
mentions🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne50%
mentions🧪Smartphone-Detected Motor Variability Correction50%
mentions🧪Enteric Nervous System Prion-Like Propagation Blockade50%
mentions🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation50%
mentions🧫Longitudinal TLR2 reporter gene study in α-synuclein mice50%
mentions🧫TLR expression in α-synuclein overexpressing mice50%
mentions🧫Dexamethasone treatment study in α-synuclein mice50%
mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna50%
mentions🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu50%
mentions🧪Optogenetic Microglial Deactivation via Engineered Inhibitor50%
mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides50%
mentions🧪Mitochondrial RNA Granule Rescue Pathway50%
mentions🧪Circadian-Synchronized LRP1 Pathway Activation50%
mentions🧪Mitochondrial Transfer Pathway Enhancement50%
mentions🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th50%
mentions🧪FOXO3-Longevity Pathway Epigenetic Reprogramming50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬Comprehensive analysis of immune cell subtypes in neurodegen50%
related🔬What cell types are most vulnerable in Alzheimers Disease ba50%
related🔬What cell types are most vulnerable in Alzheimer's Dise50%
related🔬What are the most promising therapeutic strategies for targe50%
related🔬How to break the GBA-alpha-synuclein bidirectional loop for 50%
related🔬Can gut-brain axis modulation prevent or slow Alzheimer'50%
related🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬Investigate prion-like spreading of tau pathology through co50%
see_also📖Adipose-Derived Mesenchymal Stem Cell Therapy for Early Alzh50%
see_also📖EX039 Phase 2 (NCT05413655) — Oral Therapeutic for Alzheimer50%
see_also📖LEAF Trial - THC+CBD for Alzheimer's Disease Agitation 50%
see_also📖Synaptic Therapy Alzheimer's Research Trial (START): A 50%
see_also📖The Alzheimer's Disease Tau Platform Clinical Trial (NC50%
see_also📖A Phase 3, Randomised, Double-blinded, Placebo-controlled St50%
see_also📖Master Screening Study to Determine Individuals With Potenti50%
see_also📖NCT07262645: Near-Infrared Light Therapy for Mild-Moderate A50%
see_also📖Rotigotine and Rivastigmine Combination Therapy for Alzheime50%
see_also📖APOE Lipid Metabolism Pathway in Alzheimer's Disease50%
see_also📖Endolysosomal Pathway in Alzheimer's Disease50%
see_also📖Geniposide for Alzheimer's disease - immune biomarker t50%
see_also📖Mitochondrial Dysfunction in Alzheimer's Disease Pathwa50%
see_also📖Neuroinflammation Hypothesis in Alzheimer's Disease50%
see_also📖Neurovascular Dysfunction in Alzheimer's Disease: Integ50%
see_also📖NLRP3 Inflammasome Pathway in Alzheimer's Disease50%
see_also📖Sporadic Alzheimer's Disease Pathway50%
see_also📖Synaptic Loss in Alzheimer's Disease Pathway50%
see_also📖Vascular Dementia Mechanisms — Overlap with Alzheimer's50%
see_also📖Alzheimer's Disease Biomarkers45%
see_also📖ASL Perfusion Biomarkers for Alzheimer's Disease45%
see_also📖Digital Biomarkers for Alzheimer's Disease45%
see_also📖Dried Blood Spot Biomarker Test for Alzheimer's Disease45%
see_also📖DTI Biomarkers for Alzheimer's Disease45%
see_also📖EEG Biomarkers for Alzheimer's Disease45%
see_also📖Eye-Tracking Digital Markers in Alzheimer's Disease45%
see_also📖Gait Biomarkers for Alzheimer's Disease45%
see_also📖GFAP in Alzheimer's Disease45%
see_also📖Inflammatory Biomarkers in Alzheimer's Disease45%
see_also📖Neurogranin - Alzheimer's Disease Biomarker45%
see_also📖NPTX1 and NPTXR CSF Markers Predict Alzheimer's Disease45%
see_also📖Ocular Fluid Biomarkers for Alzheimer's Disease45%
see_also📖Olfactory Biomarkers for Alzheimer's Disease45%
see_also📖Plasma Phospho-Tau Ratio Diagnostic Panel for Alzheimer'45%
see_also📖Salivary Biomarkers for Alzheimer's Disease45%
see_also📖Sleep Biomarkers for Alzheimer's Disease45%
see_also📖Speech and Cognitive Biomarkers for Alzheimer's Disease45%
see_also📖Synaptic Biomarkers for Alzheimer's Disease45%
see_also📖Tear Film Biomarkers in Alzheimer's Disease45%
see_also📖VILIP-1 and YKL-40 - Alzheimer's Disease Biomarkers45%
see_also📖Diffuse Amyloid Deposits in Alzheimer's Disease45%
see_also📖ACP-204 for Alzheimer's Disease Psychosis (NCT06159673)45%
see_also📖ASN90 Phase 2 Trial - Early Alzheimer's Disease (NCT05645%
see_also📖BIIB080 (MAPTRx) Antisense Oligonucleotide for Alzheimer45%
see_also📖BMS-986368 Phase 2 - Agitation in Alzheimer's Disease45%
see_also📖BMS-986446 Phase 2 Trial for Early Alzheimer's Disease45%
see_also📖Cannabidiol for Alzheimer's Disease Prevention (NCT058245%
see_also📖Centella asiatica Phase 1 Trial for Alzheimer's Disease45%
see_also📖EI-1071 Immunomodulator for Alzheimer's Disease (NCT06745%
see_also📖Escitalopram for Agitation in Alzheimer's Disease (NCT045%
see_also📖ExPlas — Exercise Plasma Transfusion for Alzheimer's Di45%
see_also📖Fasudil for Early Alzheimer's Disease (FEAD) - NCT0636245%
see_also📖[F-18]Flornaptitril PET - Phase 3 for Alzheimer's Disea45%
see_also📖Foralumab Phase 2 Trial for Alzheimer's Disease45%
see_also📖GSK4527226 (AL101) for Early Alzheimer's Disease (NCT0645%
see_also📖Guanfacine NorAD - Phase 3 Trial for Alzheimer's Diseas45%
see_also📖IGC-AD1 for Agitation in Alzheimer's Disease (NCT05543645%
see_also📖ITI-1284 for Alzheimer's Disease Psychosis (NCT0654083345%
see_also📖KarXT (Xanomeline/Trospium) - Phase 3 for Alzheimer's D45%
see_also📖Latrepirdine (DMB-I) Phase 3 Trial for Alzheimer's Dise45%
see_also📖NCT03875638 - Levetiracetam for Alzheimer's Disease45%
see_also📖NCT07477431 - Levetiracetam for Persons at Risk for Alzheime45%
see_also📖LHP588: P. gingivalis Targeting for Alzheimer's Disease45%
see_also📖MAR Polypill for Alzheimer's Disease (NCT06597058)45%
see_also📖Masupirdine for Alzheimer's Disease Agitation45%
see_also📖Masupirdine for Agitation in Alzheimer's Disease (NCT0545%
see_also📖MK-2214 for Early Alzheimer's Disease45%
see_also📖Nabilone for Agitation in Alzheimer's Disease (NCT0451645%
see_also📖NAB-IT: Nabilone for Agitation in Alzheimer's Disease45%
see_also📖TRAILBLAZER-ALZ 3 (NCT05026866) — Donanemab for Preclinical 45%
see_also📖GV1001 for Moderate to Severe Alzheimer's Disease (NCT045%
see_also📖Biogen Alzheimer's Disease Phase 2 Trial (NCT05399888)45%
see_also📖TRAILRUNNER-ALZ 1: Remternetug for Early Alzheimer's Di45%
see_also📖CBD (Cannabidiol) for Alzheimer's Disease Agitation - N45%
see_also📖GSK4527226 (AL101) for Early Alzheimer's Disease (NCT0645%
see_also📖KarXT for Alzheimer's Disease Cognitive Impairment - MI45%
see_also📖KarXT for Alzheimer's Disease Cognitive Impairment - MI45%
see_also📖Novartis Alzheimer's Disease Phase 2 Trial (NCT0709451645%
see_also📖NRTIs for Alzheimer's Disease - Phase 1 (NCT07210528)45%
see_also📖X/T + X-EC + Lecanemab Phase 2 (NCT07212062) — Alzheimer45%
see_also📖DMB-I (Latrepirdine) Phase 3 (NCT07251023) — Alzheimer'45%
see_also📖Exciva Alzheimer's Disease Phase 2/3 Trial45%
see_also📖NCT06582706: Nicotinic Acid for Alzheimer's Disease45%
see_also📖NRTIs for Alzheimer's Disease: Targeting Type-I Interfe45%
see_also📖ONO-2020 for Alzheimer's Disease (NCT06881836)45%
see_also📖NCT06803823 - ONO-2020 for Agitation in Alzheimer's Dis45%
see_also📖Ozanimod for Alzheimer's Disease (NCT06862960)45%
see_also📖Piromelatine 20 mg for Mild Dementia Due to Alzheimer's45%
see_also📖PLX5622 CSF1R Inhibitor Trial in Early Alzheimer's Dise45%
see_also📖Probiotics in Mild Alzheimer's Disease (NCT06181513)45%
see_also📖Recombinant Human Serum Albumin for Alzheimer's Disease45%
see_also📖Senicapoc Alzheimer's Disease Trial - NCT0480424145%
see_also📖SHR-1707 for Alzheimer's Disease (NCT06199037)45%
see_also📖Siponimod for Alzheimer's Disease (NCT06639282)45%
see_also📖SNIFF-Combo: Intranasal Insulin + Empagliflozin for Alzheime45%
see_also📖SToP-AD: Suvorexant for Alzheimer's Disease Prevention45%
see_also📖TRAP-AD: Transcranial Photobiomodulation for Alzheimer'45%
see_also📖VY7523 Phase 1/2 Alzheimer's Disease Trial45%
see_also📖Alzheimer's Disease Mechanism Index45%
see_also📖APOE4 and Alzheimer's Disease Risk45%
see_also📖CD33 Siglec Receptor Dysfunction Alzheimer's Disease Ca45%
see_also📖Cholinergic System Degeneration in Alzheimer's Disease45%
see_also📖EEG Microstates in Alzheimer's Disease45%
see_also📖Glymphatic System in Alzheimer's Disease45%
see_also📖Locus Coeruleus Degeneration in Alzheimer's Disease45%
see_also📖Metal Ion Homeostasis in Alzheimer's Disease45%
see_also📖Neuroinflammation in Alzheimer's Disease45%
see_also📖Sex-Specific Mechanisms in Alzheimer's Disease45%
see_also📖Sleep and Circadian Dysfunction in Alzheimer's Disease45%
see_also📖Tau Kinase-Phosphatase Balance in Alzheimer's Disease45%
see_also📖Tau Kinase Signaling Cascade in Alzheimer's Disease45%
see_also📖Ubiquitin-Proteasome System Dysfunction in Alzheimer's 45%
mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%
mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%
mentions🔬How to break the GBA-alpha-synuclein bidirectional loop for 40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬What are the most promising therapeutic strategies for targe40%
mentions🔬Can gut-brain axis modulation prevent or slow Alzheimer'40%
mentions🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
mentions🔬What are the mechanisms underlying autophagy-lysosome pathwa40%
mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen40%
mentions🔬What are the mechanisms underlying tdp-43 phase separation t40%
mentions🔬What are the mechanisms underlying blood-brain barrier trans40%
related🧪Smartphone-Detected Motor Variability Correction40%
related🧪Mitochondrial RNA Granule Rescue Pathway40%
related🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu40%
related🧪Enteric Nervous System Prion-Like Propagation Blockade40%
related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation40%
related🧪Optogenetic Microglial Deactivation via Engineered Inhibitor40%
related🧪Circadian-Synchronized LRP1 Pathway Activation40%
related🧪Mitochondrial Transfer Pathway Enhancement40%
related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th40%
related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides40%
related🧪FOXO3-Longevity Pathway Epigenetic Reprogramming40%
SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub